Table 2.
Association of miR-21 and p53 mRNA with Clinicopathological Data from NSCLC Patients
| Variable/Group | High miR-21 Group | Low miR-21 Group | High p53 Group | Low p53 Group |
|---|---|---|---|---|
| Histological Classification | ||||
| AD | 70 | 45 | 68 | 47 |
| SCC | 51 | 29 | 46 | 34 |
| Sex | ||||
| Male | 77 | 59 | 73 | 63 |
| Female | 35 | 29 | 30 | 34 |
| History of Smoking | ||||
| Ever | 120 | 26 | 125 | 21 |
| Never | 12 | 43 | 9 | 46 |
| Stage | ||||
| I | 4 | 60 | 7 | 57 |
| II | 13 | 38 | 8 | 43 |
| III | 33 | 14 | 27 | 17 |
| IV | 35 | 4 | 34 | 5 |
| Tumor (T) | ||||
| T1 | 6 | 47 | 4 | 49 |
| T2 | 15 | 37 | 12 | 40 |
| T3 | 32 | 17 | 36 | 13 |
| T4 | 39 | 7 | 41 | 5 |
| Lymph Node Metastasis (N) | ||||
| N0 | 10 | 62 | 12 | 60 |
| N1 | 19 | 30 | 17 | 32 |
| N2 | 31 | 14 | 34 | 11 |
| N3 | 30 | 4 | 29 | 5 |
AD, adenocarcinoma; SCC, squamous cell carcinoma.